文献速递关节外科

多次静脉氨甲环酸减少加速康复初次全髋关节置换术后隐性失血和炎症反应:一项随机临床试验

Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial.
PubMed 文献 · Bone Joint J · 2017-01-01

150例初次全髋关节置换术患者随机分为单次20 mg/kg静脉氨甲环酸组(A组)、单次后3小时追加1 g组(B组)和单次后3小时及6小时各追加1 g组(C组)。C组隐性失血显著低于A组和B组,血红蛋白下降更少,CRP和IL-6水平更低,住院时间更短,无静脉血栓栓塞或其他不良事件发生。

要点

  • C组隐性失血402.13 ml,显著低于A组679.28 ml(p<0.001)和B组560.62 ml(p=0.010)。
  • C组术后第3天血红蛋白下降21.98 g/L,少于A组30.82 g/L和B组27.16 g/L,三组差异显著(p<0.01)。
  • 三组均无静脉血栓栓塞或其他不良事件发生。

核心结论

  • 多次静脉氨甲环酸可有效减少初次全髋关节置换术后隐性失血。
  • 三次给药方案较单次给药使血红蛋白下降更少、术后炎症更轻、住院时间更短。

研究设计与样本

  • 随机临床试验,共150例初次全髋关节置换术患者随机分为三组,每组50例。
  • A组术前单次静脉氨甲环酸20 mg/kg;B组单次后3小时追加1 g;C组单次后3小时和6小时各追加1 g。
  • 所有患者采用标准围手术期加速康复方案。

主要发现

  • 平均隐性失血C组402.13 ml(标准差225.97)vs A组679.28 ml(标准差277.16),p<0.001;C组vs B组560.62 ml(标准差295.22),p=0.010。
  • 术前至术后第3天血红蛋白下降A组30.82 g/L(标准差6.31)、B组27.16 g/L(标准差6.83)、C组21.98 g/L(标准差3.72),三组差异显著(p<0.01)。
  • 术后第2天和第3天C组平均CRP水平显著低于其他两组(p≤0.034和p≤0.014)。
  • 术后前3天C组IL-6水平显著低于A组(p=0.023)。
  • C组平均住院时间显著短于A组(p=0.023),无静脉血栓栓塞或其他不良事件发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to examine the efficacy and safety of multiple boluses of intravenous (IV) tranexamic acid (TXA) on the hidden blood loss (HBL) and inflammatory response following primary total hip arthroplasty (THA). PATIENTS AND METHODS: A total of 150 patients were allocated randomly to receive a single bolus of 20 mg/kg IV TXA before the incision (group A), a single bolus followed by a second bolus of 1 g IV-TXA three hours later (group B) or a single bolus followed by two boluses of 1 g IV-TXA three and six hours later (group C). All patients were treated using a standard peri-operative enhanced recovery protocol. Primary outcomes were HBL and the level of haemoglobin (Hb) as well as the levels of C-reactive protein (CRP) and interleukin-6 (IL-6) as markers of inflammation. Secondary outcomes included the length of stay in hospital and the incidence of venous thromboembolism (VTE). RESULTS: The mean HBL was significantly lower in group C (402.13 ml standard deviation (sd) 225.97) than group A (679.28 ml sd 277.16, p < 0.001) or B (560.62 ml sd 295.22, p = 0.010). The decrease in the level of Hb between the pre-operative baseline and the level on the third post-operative day was 30.82 g/L (sd 6.31 g/L) in group A, 27.16 g/L (sd 6.83) in group B and 21.98 g/L (sd 3.72) in group C. This decrease differed significantly among the three groups (p < 0.01). The mean level of CRP was significantly lower in group C than in the other two groups on the second (p ≤ 0.034) and third post-operative days (p ≤ 0.014). The levels of IL-6 were significantly lower in group C than group A on the first three post-operative days (p = 0.023). The mean length of stay was significantly lower in group C than group A (p = 0.023). No VTE or other adverse events occurred. CONCLUSION: Multiple boluses of IV-TXA can effectively reduce HBL following primary THA. A regime of three boluses leads to a smaller decrease in the level of Hb, less post-operative inflammation and a shorter length of stay in hospital than a single bolus. Cite this article: Bone Joint J 2017;99-B:1442-9.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Xie J, Hu Q, Ma J, et al. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial. Bone Joint J. 2017. PMID: 29092982. doi:10.1302/0301-620X.99B11.BJJ-2017-0488.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。